SYNLAB Ghana breaks silence on GHC10m lawsuit over alleged HIV test error
By DL News
Published
1 min read
In a statement released on Tuesday, July 1, SYNLAB confirmed that the case is currently before the court but firmly refuted the narrative being circulated in the public domain, describing it as “inaccurate, misleading, and prejudicial.”
Medical diagnostics company SYNLAB Ghana has responded publicly to media reports surrounding a GHC10 million lawsuit filed against the firm, in which a female client alleges she lost her job and suffered reputational harm due to inaccurate HIV test results.
In a statement released on Tuesday, July 1, SYNLAB confirmed that the case is currently before the court but firmly refuted the narrative being circulated in the public domain, describing it as “inaccurate, misleading, and prejudicial.”
“While we acknowledge the individual’s right to pursue legal action, we categorically reject the misleading public discourse surrounding this issue,” the statement read.
SYNLAB disclosed that it has retained legal representation and has filed a formal defence in court, denying all allegations brought against it.
Addressing public concerns regarding its testing protocols, the company underscored its adherence to international best practices and quality assurance standards. SYNLAB Ghana is certified by Ghana’s Health Facilities Regulatory Agency (HeFRA) and holds ISO 15189:2022 accreditation from DAkkS, the national accreditation body of Germany.
“Our laboratory implements rigorous internal and external quality controls to ensure the utmost accuracy, confidentiality, and professionalism in all our diagnostic services, including HIV testing,” the statement affirmed.
SYNLAB also cautioned the media and public against the spread of unverified claims, warning that such actions not only risk misleading the public but could interfere with judicial proceedings.
“The publication in question is unbalanced and factually inaccurate. We are responding appropriately through legal channels,” the company stated.
Despite the pending litigation, SYNLAB assured its clients and stakeholders that its operations remain fully functional and its commitment to diagnostic excellence remains unchanged.
“SYNLAB Ghana continues to provide trusted, high-quality diagnostic services. This legal matter does not compromise the reliability or integrity of our operations,” the company concluded.
As the lawsuit continues to generate public interest, SYNLAB has urged all parties to refrain from sensationalism and to allow the judicial process to unfold objectively.
